The Mediterranean DASH Intervention for Neurodegenerative Delay (MIND) diet may lower a person’s risk of developing Alzheimer’s disease, according to findings published in the journal Alzheimer’s & Dementia. The study authors believed this is true even if the diet is not meticulously followed.
The largest case series to date of outcomes in patients with herpetic meningoencephalits (HME) shows early diagnosis and treatment is critical if the damage is to be held in check. Rapid treatment is common in the US, but globally, a Turkish researcher found, delays of days or even a week are not uncommon.
An upcoming study will look at an experimental delirium prevention care system to see if it can be effective in either preventing or ameliorating delirium in older patients in a hospital setting, a report in Trials explains.
Lidocaine metabolite N-ethylglycine (EG) relieves hyperalgesia and allodynia in animal models for chronic pain, suggests a study in Pain. The finding is an indicator that use of Glycine transporter 1 substrates might constitute a new drug target for the modulation of glycinergic inhibition in pain signaling.
A study in Translational Psychiatry has identified three potential genes that could prove to be responsible for disturbances in mitochondrial function and DNA repair mechanisms in bipolar disorder. The genes in question – POLG, OGG1, and NDUFV2 – may open new targets for examination. The study authors themselves consider the results to be “somewhat promising.”